Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Unknown 3Completed 2

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5Observational 4

Sponsor

Cancer Type

Gastrointestinal 1376Thoracic 266Gynecologic 187Head & Neck 179Genitourinary 165Breast 155Dermatologic 86Sarcoma 73CNS 46Other solid neoplasm 45Lymphoid 28Other hematologic neoplasm 20Endocrine 18Plasma cell 12NET 7Other neoplasm 5Myeloid 5Classical hematology 5Other 2

Conditions

Precancerous Conditions 162Leukemia 43Lymphoma 42Multiple Myeloma 39Leukemia, Lymphocytic, Chronic, B-Cell 39Neoplasms, Plasma Cell 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Non-Hodgkin 35Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Immunoblastic 35Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Follicular 35Monoclonal Gammopathy of Undetermined Significance 34Burkitt Lymphoma 34Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 33Lymphoma, B-Cell, Marginal Zone 33Myeloproliferative Disorders 32Myelodysplastic Syndromes 32Leukemia, Myeloid, Acute 32Hodgkin Disease 32Immunoblastic Lymphadenopathy 31Lymphoma, Large-Cell, Anaplastic 30Immunoglobulin Light-chain Amyloidosis 30Waldenstrom Macroglobulinemia 29Primary Myelofibrosis 29Thrombocythemia, Essential 28Leukemia, Hairy Cell 28Leukemia, Biphenotypic, Acute 28Lymphoma, T-Cell, Cutaneous 27Leukemia, Prolymphocytic 27

Interventions

Endoscopy 2High-Throughput Screening Assays 1Esomeprazole 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Endoscopic Mucosal Resection 1Biopsy 1Aspirin 12-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Esophageal Neoplasms × Other neoplasm × Clear all
NCT00357682 2025-05-01

AspECT

University of Oxford

Phase 3 Completed
2,557 enrolled 17 charts
GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT00987857 2017-08-22

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Gloucestershire Hospitals NHS Foundation Trust

Phase NA Unknown
3,400 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT00903136 2014-01-10

Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus

National Cancer Institute (NCI)

Phase 1/2 Unknown
50 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT00281736 2014-01-03

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Roswell Park Cancer Institute

Phase 2 Completed
60 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT00566800 2013-09-17

Erlotinib in Treating Patients With Barrett Esophagus

National Cancer Institute (NCI)

Phase 1 Unknown
25 enrolled
GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡